Literature DB >> 35020844

Leptin-reactive antibodies are distinctly correlated with body composition parameters and metabolic risk indexes in children and adolescents.

Rafael Vázquez-Solórzano1, Elia Valdés-Miramontes2, Mildren Porchas-Quijada1, Mayra Enciso-Ramírez1, Guadalupe A Contreras-Mata2, Alma Gabriela Martínez-Moreno2, Lourdes Barajas-García2, Astrid Selene Espinoza-García1,2, Zyanya Reyes-Castillo1,2.   

Abstract

Studies have demonstrated the presence of low-affinity immunoglobulins (Igs) directed to leptin, a key hormone of the neuroendocrine axis that regulates appetite and metabolism, in adult healthy subjects, patients with obesity, and type 2 diabetes mellitus. In the present exploratory study, IgG leptin-reactive antibodies were analyzed for the first time in children and adolescents according to body mass index (BMI) and were correlated with biochemical profile (lipid profile, insulin, glucose, and leptin) and metabolic risk indexes [homeostasis model assessment for insulin resistance (HOMA-IR), homeostasis model assessment for β-cell function (HOMA-β), atherogenic index of plasma (AIP)]. One hundred and thirty-six participants were included (children n = 63, adolescents n = 73). An in-house enzyme-linked immunosorbent assay (ELISA) test was performed to measure IgG anti-leptin antibodies (free, total, and immune complexes). In adolescents, free and total IgG anti-leptin antibodies levels were higher in groups with overweight or obesity than in normal-weight group (P < 0.01), while in children, the total fractions were lower in groups with overweight and obesity than in normal weight (P < 0.02). Immune complexes percentage showed opposite correlations with BMI in children (r = 0.4004, P = 0.0473) and adolescents (r = -0.3983, P = 0.0133). IgG anti-leptin antibodies were also correlated with HOMA-IR in children (r = -0.4569, P = 0.0217) and adolescents (r = -0.3589, P = 0.0316), and with AIP (r = -0.3608, P = 0.0261) in adolescents. Our data suggest that the production and affinity of IgG anti-leptin antibodies can be affected by age, body composition, and metabolic conditions; additionally, in normal conditions, IgG anti-leptin antibodies may have a protective role in insulin resistance and cardiovascular events.
© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Immunology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  anti-leptin autoantibodies; atherogenic risk; insulin resistance; leptin resistance; obesity

Mesh:

Substances:

Year:  2022        PMID: 35020844      PMCID: PMC9188341          DOI: 10.1093/cei/uxab001

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   5.732


  51 in total

1.  B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies.

Authors:  Daniel A Winer; Shawn Winer; Lei Shen; Persis P Wadia; Jason Yantha; Geoffrey Paltser; Hubert Tsui; Ping Wu; Matthew G Davidson; Michael N Alonso; Hwei X Leong; Alec Glassford; Maria Caimol; Justin A Kenkel; Thomas F Tedder; Tracey McLaughlin; David B Miklos; H-Michael Dosch; Edgar G Engleman
Journal:  Nat Med       Date:  2011-04-17       Impact factor: 53.440

2.  Neuropeptide autoantibodies assay.

Authors:  Sergueï O Fetissov
Journal:  Methods Mol Biol       Date:  2011

3.  Metabolic syndrome in Mexican children: Low effectiveness of diagnostic definitions.

Authors:  Barbara Itzel Peña-Espinoza; María de Los Ángeles Granados-Silvestre; Katy Sánchez-Pozos; María Guadalupe Ortiz-López; Marta Menjivar
Journal:  Endocrinol Diabetes Nutr       Date:  2017-06-03

4.  Development of a WHO growth reference for school-aged children and adolescents.

Authors:  Mercedes de Onis; Adelheid W Onyango; Elaine Borghi; Amani Siyam; Chizuru Nishida; Jonathan Siekmann
Journal:  Bull World Health Organ       Date:  2007-09       Impact factor: 9.408

5.  Increased serum IgG and IgA in overweight children relate to a less favourable metabolic phenotype.

Authors:  J Bassols; A Prats-Puig; M Gispert-Saüch; M Crehuet-Almirall; G Carreras-Badosa; F Díaz-Roldán; M Montesinos-Costa; F de Zegher; L Ibáñez; A López-Bermejo
Journal:  Pediatr Obes       Date:  2013-04-02       Impact factor: 4.000

Review 6.  The cellular and molecular bases of leptin and ghrelin resistance in obesity.

Authors:  Huxing Cui; Miguel López; Kamal Rahmouni
Journal:  Nat Rev Endocrinol       Date:  2017-02-24       Impact factor: 43.330

Review 7.  Obesity, Fat Mass and Immune System: Role for Leptin.

Authors:  Vera Francisco; Jesús Pino; Victor Campos-Cabaleiro; Clara Ruiz-Fernández; Antonio Mera; Miguel A Gonzalez-Gay; Rodolfo Gómez; Oreste Gualillo
Journal:  Front Physiol       Date:  2018-06-01       Impact factor: 4.566

8.  Affinity kinetics of leptin-reactive immunoglobulins are associated with plasma leptin and markers of obesity and diabetes.

Authors:  Houda Bouhajja; Noura Bougacha-Elleuch; Nicolas Lucas; Romain Legrand; Rim Marrakchi; Srini V Kaveri; Kamel Jamoussi; Hammadi Ayadi; Mohamed Abid; Mouna Mnif-Feki; Sergueï O Fetissov
Journal:  Nutr Diabetes       Date:  2018-05-24       Impact factor: 5.097

Review 9.  Adipose Tissue Immunomodulation: A Novel Therapeutic Approach in Cardiovascular and Metabolic Diseases.

Authors:  Ibrahim AlZaim; Safaa H Hammoud; Houssam Al-Koussa; Alaa Ghazi; Ali H Eid; Ahmed F El-Yazbi
Journal:  Front Cardiovasc Med       Date:  2020-11-17

10.  Inhibition of endogenous leptin protects mice from arterial and venous thrombosis.

Authors:  Stavros Konstantinides; Katrin Schäfer; Jaap G Neels; Claudia Dellas; David J Loskutoff
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-09-30       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.